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Atherosclerosis is a systemic inflammatory vascular disease, involving multiple 
arterial beds and is associated with the progressive accumulation of lipids, calcium, blood 
components, carbohydrates and fibrous tissue on the intimal layer of greater and medium-
sized arteries, leading to the invasion of leukocytes and smooth muscle cells into the 
intima, a process that leads to the formation of atherosclerotic plaques. Despite the fact 
that improvement of pharmacotherapy and revascularization have significantly optimized 
the prognosis of patients with atherosclerotic vascular disease, myocardial infarction and 
stroke remain the major causes of mortality worldwide.  
Patients with symptomatic atherosclerotic disorder on a certain organ, e.g. heart - 
ischemic heart disease (IHD), are not only on a risk of acute myocardial infarction (AMI) 
but also on high-risk of clini9cal manifestations from the brain e.g. transient ischemic 
attack (TIA) or ischemic stroke mainly due to carotid artery stenosis, or appearance of 
clinical manifestations from the limbs (Peripheral arterial disease). Patients with history 
of TIA or ischemic stroke due to carotid artery stenosis (CAS) show two or three times 
higher risk for AMI compared to the general population. Likewise, patients with IHD 
have three times higher risk for TIA or ischemic stroke, while patients with PAD have 
three or four times higher risk for developing ischemic heart failure compared to the 
general population.  
The asymptomatic carotid artery stenosis is associated with increased prevalence 
of IHD and the annual risk of AMI is high, ~ 3-5%. The prevalence rate of asymptomatic 
CAS >50% is estimated to be around 2-8% and that of asymptomatic CAS >80% 
between 1-2%. Correlation between several (vascular) risk factors and CAS has been 
demonstrated by many studies. The evaluation of the cardiovascular risk factors, classical 
either new markers like carotid intima-media thickness (cIMT), the coronary artery 
calcium (CAC) score and the evaluation of morphological characteristics of the 
atherosclerotic plaque, will help us to detect and stratify patients in high risk for 
cardiovascular disorders like IHD, especially those who are still asymptomatic. 
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In this review, are discussed the major studies regarding the risk stratification for 
cardiovascular disorders and especially for IHD in patients with asymptomatic carotid 
stenosis, providing the readers with an insightful analysis, in order to assist in selecting 
potential candidates for cardiovascular intervention. It is very important the establishment 
of a diagnostic method that can accurately extract the group of patients who have the 
highest future risk of developing ischemic heart disease. Thus, early recognition of 
patients at higher risk would maximize the potential benefits of revascularization or 
optimal medical therapy (OMT), as well as would ameliorate the prognosis. 
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Nowadays cardiovascular diseases (CVDs) are one of the major mortality causes in 
both developed and developing countries. In particular, Alexopoulos [1] notes that 
cardiovascular disease is the most common cause of death among European men under 
65 years old and second most common in women. In addition, Tutuzas [2] observe that 
atherosclerotic disease is the main cause of death especially in developed countries. 
CVDs are characterized by the presence of atherosclerosis in the body’s vessels, also 
known as atherosclerotic disease consisting of atherosclerotic plaques. 
Initially, it is necessary to define the word atherosclerosis. The word atherosclerosis is 
etymologically derived from the ancient word "athyroma", which means "powdered 
cereal". Hippocrates used this word to describe the fatty core of atherosclerotic plaques. 
Later, Filis [3] highlights that atheromatous disease was previously described as a 
degenerative disease, inevitable of ageing. However, recent research has shown that the 
hypothesis of old age is obsolete and atherosclerosis is now described as a chronic 
inflammatory condition that is preventable. 
More specifically, atherosclerotic disease according to Grigoriadou-Manousaki  is a 
chronic disease which leads to the formation of atherosclerotic plaques on the inner layer 
of the arteries in combination with hardening and loss of elasticity of the arterial wall [4]. 
Atherosclerotic disease has the ability to  affect large and medium-sized arteries. Thus, 
atherosclerotic plaques cause stenosis or even obstruction of the arterial lumen resulting 
in tissue and organ ischemia. Atherosclerotic plaques consist of lipids, mainly 
cholesterol, mostly in complexes with proteins, cholesterol esters, inflammatory cells, 
fibrous tissue and thrombi. Atherosclerosis [5, 6] is a progressive disease that initiates 
early in childhood but its clinical manifestations appear usually in the middle age and 
beyond. The basic morphological alteration is the atherosclerotic plaque or atheroma, 
which is formed in the intima of the artery and develops slowly and silently without 
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clinical symptoms for many years, is initially asymptomatic. Haztintuntas [7] describes 
the four stages of atherosclerotic changes in the arterial wall. Stages 1 and 2 include 
thickening of the tunica intima of the vessel and formation of vacuolar cells-macrophage 
cells characterized by accumulation of cholesterol, stage 3 is characterized by 
accumulation of extracellular lipids, stages 4 and 5 are characterized by atheromatous 
plaque formation, while stage 6 involves complicated lesions. 
Finally, according to Tutuzas (2010), the most severe clinical manifestation of 
atheromatosis of arteries, which are characterized by very high mortality and morbidity, 
are the manifestations of acute coronary syndrome (ACS), as well as stroke [2]. In 
particular, according to estimations, by 2030 40% of the overall mortality will be owed to 
atherosclerotic disease. Kremastinos emphasizes that it is important to investigate any 
kind of atherosclerosis because it is inevitable that in the future it will cause myocardial 
infarction (MI), stroke, or rupture of the aneurysm of the arteries or thrombosis of the 
arteries [8]. 
1.1.1 Epidemiology of atherosclerosis 
 
Atherosclerosis-related cardiovascular diseases (coronary artery diasese, ischemic 
heart disease, cerebrovascular diasease and peripheral arterial disease) it is estimated to 
be the world's leading cause of death by 2020 [9]. Atherosclerotic carotid artery stenosis 
above 50% is responsible for 15-20% of stroke including Transient Stroke (TIAs) [10-
11]. Hemodynamically significant carotid stenosis> 50% has an incidence of 1-3% 
worldwide. Above 65 years, the average incidence is increased to 6.9% [12]. The 
incidence of asymptomatic carotid stenosis varies according to gender and age. In a 
recent study [13] based on population studies, a narrowing of> 50% was observed in 
4.8% of men and 2.2% in women below 70 years old. Those rates were increased to 
12.5% for men and 6.9% for women when the population age was above 70 years. While 
severe asymptomatic stenosis of 70% or higher has an incidence of 0-3.1% in the general 
population [14]. 
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A recent systematic review and meta-analysis [13] estimated the incidence of 
asymptomatic carotid stenosis as follows: Incidence of 4.2% (95% Confidence Interval 
(CI) 3.1 to 5.7) for a 50% or greater and incidence of 1.7% (95% Confidence Interval 
(CI), 0.7 to 3.9), for a stenosis of 70% or greater. 
The Cardiovascular Health Study demonstrated a five-year risk of 5% for the 
occurrence of fatal or non-fatal stroke in a patient with asymptomatic carotid stenosis 
with a stenosis of 70% or greater [15]. Recent data show that patients with asymptomatic 
stenosis of the internal carotid arteries of> 50% have stroke at a rate of 0.5-1% annually 
[16, 17]. 
As a result of the aging of the population and the increase in the incidence of carotid 
disease, with increasing age, asymptomatic carotid disease is expected to become a 
frequent entity in today's clinical practice in the near future [18]. 
      1.1.2    Pathophysiology of atherosclerosis 
 
Atherosclerosis is caused by the development of lesions in the wall of the arteries. 
Kremastinos (2009) reports that the core of atherosclerotic plaques is mainly composed 
of oxidized LDL cholesterol with calcium deposition [8]. These plaques are surrounded 
by a fibrous tissue capsule that progressively grows and narrows the arteries gradually or 
weakens their wall, causing their wall to be stretched and create aneurysms. 
Atherosclerosis begins since adolescence or adulthood in the form of lesions of the tunica 
intima of the arteries. Atherosclerotic plaques are infiltrated by inflammatory cells, 
thereby weakening the fibrous capsule (FB) and at some point breaking and creating a 
thrombus that occludes the artery abruptly and causes the MI or stroke. The process of 
inflammation is signaled by the production of specific proteins and their antibodies 
circulating in the blood. Hence, if we detect these substances we can suspect the 
incidence of a potential cardiovascular event. 
Concurrently, atherosclerosis is a complex evolutionary and systematic disease of 
the arteries that primarily affects the tunica intima of the large and middle-sized arteries 
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of systemic circulation. Chronic inflammatory response plays an important role regarding 
the activation of the pathophysiology of the disease and the infiltration of the tunica 
intima from monocytes-macrophages and T lymphocytes in combination with coexisting 
endothelial dysfunction and the accumulation of oxidized LDL are the dominant findings 
of atherogenesis [19]. 
Hypercholesterolemia, hypertension, smoking and oxidative reactions, occurring 
in all forms of inflammation destroy or injure endothelial cells of the vessel that results in 
premature atherosclerosis, which starts from the endothelium. LDL cholesterol plays 
major role in the formation of the atherosclerotic plaque. The early atherosclerotic lesion 
is called as fatty streak which is formed in the tunica intima of the arteries by circulating 
lipids. In addition, exogenous and endogenous factors such as smoking, age, 
hypertension, diabetes mellitus (DM) and dyslipidemia, accelerate the growth of 
atherosclerotic plaque in size by accumulated lipids, inflammatory cells and fibrous tissue 
and may cause partial or complete occlusion arterial lumen. 
 
Figure 1."Vascular Wall Changes on Atherosclerosis" 
Endothelial cells regulate dilatation of smooth muscle fibers through nitric oxide 
and contraction through endothelin release. Endothelin acts on platelets and on the 
subendothelial tissue. In addition, it is necessary for the healing process of small and 
medium-sized wounds. It also stimulates endothelial cells and monocytes/macrophages. 
The high-density lipoprotein (HDL) does not penetrate the endothelium. In contrast, low-
density lipoprotein (LDL) can be oxidized and penetrate the endothelium in the form of 
oxidized lipids. Oxidized LDL is toxic to macrophages and it can’t be discarded. 
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Thereinafter, cells are self-destructed and die - necrosis of the fatty cells. Each dead cell 
is an additional stimulus for the body which then attempts to self-protect by activation of 
the immune system. Macrophages and smooth muscle cells migrate to the lumen of the 
vessel, where they settle beneath the endothelial cells and get multiplied. As a result, the 
endothelium progressively protrudes into the lumen and loses its smooth surface. This 
ongoing procedure is known as neoendotheliosis which narrows the vascular lumen and 
results in turbulent blood flow, which stimulates the endothelium and this causes a 
vicious cycle. 
Furthermore, atherosclerosis results in target organ damage from ischemia and 
atherothrombosis-atheroembolism. Endothelial injury by platelet aggregation or 
macrophage necrosis promotes the proliferation of monocytes and smooth muscle cells 
that migrate to the lesion area. This process continues for many years due to the 
permanent mechanical or lipidemic loading that is transmitted to the endothelium [8]. 
Finally, the lipid-rich plates may rupture (unstable atherosclerotic plaque). At the 
point of rupture, platelets accumulate and a blood clot forms that can completely occlude 
a previously open arterial lumen. Sudden arterial occlusion due to rupture of the 
atherosclerotic plaque is now considered to be the predominant mechanism for the 
manifestation of acute ischemic events, and in particular acute coronary events. In 
addition, a portion of the ruptured atherosclerotic plaque can detach and cause embolism 
at peripheral sites (atheroembolism) of the arterial network [4]. 
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Figure 2. "The progression of Atherosclerosis" 
 
1.1.3 Classical and novel risk factors of atherosclerosis 
 
Parameters and diseases that occur more frequently in people who develop 
"premature" atherosclerosis than the general population are defined as "risk factors" and 
are as follows: 
1. Hyperlipidemia 
2. HDL-cholesterol 
3. Arterial hypertension 
4. Smoking 
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5. Diabetes mellitus (DM) 
6. The family history of myocardial infarction less than 55 years for men or less than 65 
years for women 
7. The male sex 
8. The history of cerebrovascular disease or PAD 
9. Obesity  
10. Sedentary lifestyle 
11. The high concentration of Lp (a) (> 30mg / dl) 
Nowadays, high concentration of fibrinogen has begun to be evaluated as a risk 
factor, particularly when deciding to treat hyperlipidemia [20]. The co-existence of risk 
factors of more than one greatly increases the level of risk. The result is not cumulative 
but multiplicative [20]. 
However, early diagnosis and treatment, avoiding the parameters established as 
risk factors, especially when treated from an early age [21], there is no doubt that it will 
help to prevent and reduce the mortality of cardiovascular disease. 
The severity of classical risk factors for the development of atheromatosis varies 
across the arterial beds and the coexistence of risk factors beyond one, greatly increases 
the level of risk for premature atherosclerosis [22]. Hypertension is one of the most 
important risk factors for atherosclerosis. According to the studies of Delker et al., and 
Grouse et al., there was a remarkable relation between hypertension and 
hypercholesterolemia with carotid atherosclerosis and IHD [23, 24]. 
DM is considered equivalent to coronary artery disease (CAD) and vice versa 
many patients with CAD have already had diabetes [25]. DM has been suggested by 
several researchers as an independent risk factor for atherosclerosis of carotids and 
coronary arteries [26, 23]. However, it was demonstrated moderate correlation of DM in 
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the general population, with both CAD and atherosclerosis of the carotid arteries. In 
addition, the correlation was strong in women with DM with CAD and atherosclerosis of 
carotids. Thus, diabetes is the more important risk factor for CAD in women than in men. 
This risk certainly becomes even greater when other risk factors, such as arterial 
hypertension, obesity and smoking [27] coexist. Smoking also has been shown that 
increases the risk of cardiovascular disease. Based on the data provided by the WHO, 
80% of premature deaths that were caused by heart disease and stroke could be avoided 
with healthy eating, systematic physical activity and smoking cessation [25]. 
According to Dandoulakis  the risk of CAD is rising with a positive family history 
in first-degree relatives as the number of family members with coronary artery disease 
increases and as younger is the age at which family members developed CAD [25]. Early 
atherosclerosis often occurs in members of the same family. In many cases, this can be 
attributed to the hereditary transfer of risk factors such as hypertension, hyperlipidemia 
and DM. In the studies of Hamby et. Al., and Ten Kate et., Al demonstrated families with 
severely premature vascular disease, where none of the known risk factors showed any 
impact. Family history is one of the most important factors regarding the clinical 
evaluation of the patients. A positive family history is significantly associated with 
carotid and coronary atherosclerosis [28, 29]. 
In addition, according to many studies it is well known that physical exercise has a 
wide range of beneficial effects on the atherosclerosis progression, resulting in 20% -25% 
reduction in overall cardiovascular mortality [25]. 
 
1.2 Carotid disease 
1.2.1 Epidemiology of carotid disease 
 
It is estimated that 5-10% of people over 65 have a carotid stenosis over 50% that 
maybe asymptomatic. Among those suffering from CAD or PAD, the percentage of those 
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with carotid disease is 20-30%. According to bibliography, ultrasound screening of 
carotid arteries is indicated after 50 years of age in individuals who have at least one of 
the risk factors for atherosclerosis. Men under 75 have a higher risk of developing a 
carotid disease than women in the same age group, while, women are at greater risk than 
men are over 75 years [7]. 
According to clinical studies, mostly atherosclerotic plaques in the carotid artery are 
located in the carotid bifurcation and approximately 40% at the beginning of the ICA 
[30]. In addition rupturing an atherosclerotic plaque is more often seen in the left CCA. 
 
1.2.2 Anatomy of carotid arteries 
 
The right common carotid artery arises from the anonymous artery, while the left 
common carotid arises from the aortic arc. Each common carotid artery is directed in the 
cervix and divided into two other branches, the internal carotid artery (ICA) and the 
external carotid artery (ECA). The ECA blood supplies most of the face, throat, larynx 
and lower jaw through its lateral branches. The ICA is the continuation of the common 
carotid pathway after the split. It crosses the base of the skull with the carotid canal, 
advances into the cavernous sinus and divides into four branches, the anterior cerebral 
artery, the anterior choroidal artery, the posterior communicating artery and the middle 
cerebral artery. The ocular artery is a collateral branch of the ICA. The most important 
part of the brain vessels comes from the ICA. ICA consists of four main sections: the 
cervical, the petrous, the cavernous and the supraclinοid. 
The two ICA are supplying most of the anterior brain circulation. The two vertebral 
arteries that protrude from the subclavian arteries through the basal artery, supply most of 
the posterior circulation of the brain. The cerebral branches of the carotid arteries and the 
spinal arteries communicate at the base of the brain at Willis arterial circle. 
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At the bifurcation of common carotid artery, the enlarged final end of the common 
carotid artery forms the carotid sinus, while the enlarged initial end of the ICA forms the 
carotid bulb. In the outermost carotid layer of the carotid sinus, there are many nerve 
fibers, which act as baroreceptors for the reflex regulation of blood pressure.  
 
1.2.3 Pathophysiology of carotid disease  
 
Carotid arteries and spinal arteries are branches of the aorta directing from the 
cervix towards the sculp, carrying blood rich in oxygen and nutrients to the brain. Carotid 
arteries belong to the class of elastic arteries and it is a large diameter vessel. The wall of 
the common carotid consists of three layers from inside towards outside, tunica intima, 
tunica media and tunica adventitia. The intima consists of an endothelial layer and a thin 
basement membrane. It is noted that in young people with a healthy carotid wall, the 
intima is thin enough and its contribution to the mechanical properties of the arterial wall 
is insignificant and with the progress of age, the thickness of the intima increases with the 
contribution of the mechanical behavior of the wall to become more important. The 
tunica media contains smooth muscle cells as well as a water matrix containing 
proteoglycans. Finally, the tunica adventitia consists of a dense network of collagen 
fibers along with elastin, nerves and fibroblasts, a layer that restricts the acute 
overdilation of the vessel. 
Pathological changes of the tunica intima components are associated with the 
development of atherosclerosis. Atherosclerotic disease affects large and medium-sized 
arteries and is characterized by endothelial dysfunction, vascular inflammation, lipid 
accumulation, cholesterol and calcium as well as cellular debris within the tunica intima. 
The deposition of these materials causes the formation of atherosclerotic plaque that was 
described in a previous chapter in details, which may cause stenosis or obstruction in the 
lumen of the vessel. As more and more material accumulates, the arteries narrow and 
harden and this atherosclerotic process may extend to such an extent that decrease or 
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disrupt blood flow through the carotid, then this is called carotid artery disease or carotid 
obstructive disease. 
 The presence of atherosclerosis in the carotid arteries may cause disturbances in 
normal blood circulation and decreased blood supply [31]. This results in reduced blood 
supply to the brain and therefore increases the risk of stroke [32]. Stroke is the third cause 
of death in the developed countries and the first cause of disability in Europe. Carotid 
disease is responsible for 25% of cerebrovascular events. Studies and clinical data 
demonstrate that the probability of incidence of ischemic stroke is significantly increased 
when the carotid stenosis is over 60-70%. According to Sacco et al., the degree of carotid 
stenosis does not always predict which patients will develop symptomatic disease [33]. 
Patients with severe carotid stenosis and especially symptomatic patients are at high risk 
for stroke, in particular the likelihood of an individual suffering from ischemic stroke 
increases significantly when the carotid stenosis is over 60-70% [34]. However, even low 
grade carotid stenosis can also lead to stroke. 
Regarding the causes of carotid disease: 90% of carotid damage is due to 
atherosclerosis, while the remaining 10% is due to aneurysms, arteritis, carotid artery 
dissection, fibromuscular dysplasia, radiation and vasospasm.  
 
 
1.2.4 Clinical manifestations of carotid disease  
 
When atherosclerosis affects the carotid arteries, it may be revealed by a lot of 
symptoms, mainly by neurological conditions such as transient ischemic attack (TIA) or 
stroke. The main symptoms-manifestations are the followings: syncope, sudden loss of 
vision, blurred vision, or difficulty seeing one or both eyes, tingling or numbness on one 
side the face or one side of the body, sudden confusion and/or dizziness, aphasia, 
difficulty in speaking, sudden severe headache and memory problems, or even death [35]. 
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Patients with neurological and ophthalmic symptoms, with audible though auscultation 
carotid murmur or with atherosclerotic disease in other areas of the body, the patient 
should be referred for ultrasound examination of carotid arteries [36]. 
1.2.5 Diagnostic approach of carotid disease  
• Color Doppler Ultrasound (CDU) 
High-resolution ultrasound scanning of blood vessels using B-scan and Doppler 
ultrasound provides information not only on the grade of stenosis but also on the 
characteristics of the arterial wall including the size and composition of atherosclerotic 
plaques [37]. The sensitivity and specificity of CDU for detection of stenosis > 60% is 
94% and 92%, respectively [38]. CDU scanning in a certified diagnostic laboratory is the 
initial imaging method for estimating the degree of stenosis in symptomatic and 
asymptomatic patients and the method of screening for the screening control of high-risk 
asymptomatic patients. The recognition of a 50-99% stenosis in symptomatic neurologic 
patients or 70-99% in asymptomatic patients is sufficient to make a therapeutic decision 
for surgery [39]. 
• Axial Angiography (CTA), Magnetic Angiography (MRA), Digital Abstracted 
Angiography (DSA) 
When CDU is non-diagnostic or demonstrates of intermediate grade stenosis (50-
69%) in an asymptomatic patient, additional visualization with (MRA, CTA or DSA) is 
required prior to any kind of intervention. When it is required pre-invasive control of 
proximal or intracranial carotid segments in order to decide the type of treatment, further 
(CTA, MRA or DSA) control is indicated. CTA is preferred compared to MRA due to its 
superiority in the detection of calcifications. The sensitivity and specificity of CTA for 
detection of 70-99% stenosis is 85% and 93% respectively, while for detection of total 
obstruction is 97% and 99% respectively [40]. In a study of 2005, MRA showed 100% 
sensitivity and 99.3% specificity to detect >70% stenosis and total obstruction [41]. 
When there is a deviation between two minimally invasive diagnostic methods (US, 
MRA, CTA), it is indicated to perform DSA in order to clarify the results. DSA is 
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important when there are ambiguities about the grade of stenosis from the minimally 
invasive methods, or if it is scheduled a transcatheter opening of carotid artery [39]. 
1.2.6 Treatment of carotid disease  
 
Carotid Disease is predominantly treated by modifying risk factors, essentially by 
changing a person's lifestyle, such as stopping smoking, limiting alcohol, controlling and 
regulating blood pressure and cholesterol, weight loss and daily exercise in order to 
decelerate the progression of atherosclerosis and thereby decelerate the increase in 
carotid stenosis. 
In the treatment of carotid disease, antiplatelet therapy is mandatory in order to 
inhibit platelet function by reducing adherence of platelets to the atherosclerotic plaque, 
thereby reducing the chance of rupturing the atherosclerotic plaque and detachment of its 
fragments transporting it towards brain causing potential athero-embolic events in brain.  
Another very importan weapon in order to treat carotid disease are statins, which retard 
atherosclerosis and reduce LDL [35]. 
Another way to treat carotid disease is surgical intervention and carotid 
endarterectomy (CEA), which is the most common procedure for carotid opening and it 
has very good and long-term results. In addition, carotid artery angioplasty with stent 
placement, in which the carotid artery stenosis is opened with a balloon under 
radiological control [35]. Surgical treatment is the most prevalent method in patients with 
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1.3 Novel and classical ultrasonographic markers with diagnostic and predictive 
value 
 
1.3.1 Characteristics of atheromatous plaque of the carotid bifurcation (degree of 
stenosis, morphology of carotid plaque) 
 Severity of stenosis 
The analysis of the results of two large randomized clinical trials (ECST and 
NASCET) according to which the grade of stenosis has been established as the key factor 
regarding therapeutic decisions in carotid disease, demonstrated that the percentage of 
stenosis (but not> 99%) was predictive of increased risk for stroke in patients treated with 
medication [42]. However, studies regarding endarterectomy for asymptomatic carotid 
artery stenosis, like ACAS [43] and Carotid Surgery Trial (ACST) [44] did not indicate 
that a) the increase in the grade of stenosis, b) bilateral severe stenosis, and c) severe 
stenosis and heterolateral obstruction were predictive of stroke in patients treated with 
medical therapy [45]. 
  In order to limit the number of purposeless surgical interventions in patients with 
asymptomatic stenosis> 70%, with the only criterion to be the grade of stenosis, the last 
decades several imaging tools have been developed for the effective morphological 
description of atherosclerotic plaques and accurate prediction of the overall 
atherosclerotic "load" of each patient. 
Carotid Intima-Media Thickness (cIMT)    
B-mode ultrasound is a widely used and important tool for examining the vessel wall 
and assessing atherosclerotic plaques of the carotids. Intima Media complex consists of 
endothelial cells, connective tissue and smooth muscle cells and is a part of the vessel 
where the atherosclerotic plaque develops [46]. 
Pathological thickening of tunica intima of the arteries is the most common and most 
commonly detectable clinical manifestation of atherosclerosis [47, 48]. The thickness of 
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the intima-media is not only an early marker of atherosclerosis but also a marker of 
hypertrophy/hyperplasia of the smooth muscle tissue that may be associated with genetic 
factors, hypertension and age-related vascular wall hardening [49]. 
The effect of arterial hypertension on the IMT of common carotid artery (CCA-IMT) 
was indirectly studied in the RADIANCE study, which showed that CCA-IMT is more 
influenced by BP and less than atherosclerosis [50]. 
The CCA-IMT measurement has multiple advantages in monitoring atherosclerosis as 
it can be performed without side effects and without radial overload for patients. At the 
same time, it is a low-cost method and provides accurate information about 
atherosclerotic ‘’load’’ of vessels, in addition to traditional risk factors. In addition, 
CCA-IMT measurements have been found to conform to microscopic pathological 
studies [51, 52]. 
The cIMT measurement includes the estimation of the combined thickness of the 
intima and media wall of the carotid artery. This combined measurement, as the existing 
technology in ultrasonographic devices (using standard probes) provides insufficient 
longitudinal resolution for the discrimination of tunica intima and media (20% is intima 
and 80% is media) [53]. In case of healthy intima-media complex, 97.5% consists of the 
tunica media, while when there is atherosclerotic disease, 80% of the IMT consists of the 
tunica media [54]. Ultrasonographically, IMT is defined by a double line that is depicted 
at the proximal and distal wall of the common carotid arteries in longitudinal view. It is 
delineated by two parallel lines consisting of the edges of two anatomical boundaries: the 
border lumen-tunica intima and the border tunica media-adventitia[55]. 
Technique of measuring IMT    
When measuring, the various parts of the arterial wall (common carotid, carotid 
bulb) should be displayed in a longitudinal section perpendicular to the ultrasound beam. 
Both vascular walls (proximal and distal) should be clearly displayed so that 
measurements of the diameter to be feasible. The ideal diameter of the vessel lumen 
should be calculated during diastole of the heart in a sequence of pictures (cine-loop). At 
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the recorded area it should be clearly distinguished the borders of lumen-intima/media-
adventitia layers. cIMT should be measured at the distal wall of the CCA at a distance of 
0.5 cm from the carotid bulb and for one centimeter longitudinally [56]. (figure 3) 
Ultrasonographic definition of atheromatous plaque 
Atherosclerotic plaques are defined ultrasonographically as focal structures that 
project within the arterial lumen, at least 0.5 mm or 50% relation to the adjacent IMT 
value or if they have a thickness of> 1.5 mm [56]. (Figure 4) 
The thickness of Intima-Media (IM) in clinical practice 
Endothelial thickness and presence of atherosclerotic plaque are recommended for 
the initial assessment of total cardiovascular risk in asymptomatic patients of 
intermediate risk with two or more cardiovascular risk factors according to the NCEP and 
coexisting metabolic syndrome with a family history premature cardiovascular disease, a 
known CAC score 0 and Framingham Risk Score (FRS), equal to 11-12% [56]. 
The predictive value of cIMT 
The Kuoppio Ischaemic Heart Disease study was the first to show a correlation 
between cIMT and future coronary events. In this study, each 0.1 mm IMT increase was 
accompanied by an 11% increase in risk for MI during follow up [57]. A meta-analysis 
[58], which included data from eight studies (31,197 patients) where patients were 
followed-up on average for 5.5 years, showed that the risk of MI and stroke was 1.26 
(95% confidence interval [ CI] 1.21-1.30 based on age and gender). 
For each 0.1 mm difference in IMT, the probability of manifestation MI and 
stroke was 1.15 (1.12-1.17) and 1.18 (1.16-1.21) respectively. Even after taking into 
consideration all the cardiovascular risk factors, IMT remained an independent 
prognostic factor for the manifestation of cardiovascular event. Recently studies have 
shown that the combination of conventional risk factors for IHD with IMT improves the 
prognosis for IHD in diabetic patients and that endothelial thickness is useful for 
identifying high-risk patients for macrovascular complications of diabetes [59]. 
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Other major clinical trials such as: 
• ARIC (Atherosclerosis Risk in Communities) study [60] 
• CHS (Cardiovascular Health Study) [61] 
• CAPS (Carotid Atherosclerosis Progression Study) [62] 
• MDCS (Malmo Diet and Cancer Study) [63] 
• Rotterdam Study [64] 
showed that CIMT can be used to assess the imminent cardiovascular risk. 
A recent meta-analysis of a large population (45828 patients) that assessed only 
the endothelial thickness of the CCA excluding the presence of carotid plaques or IMT 
measurements in the bulb demonstrated that measurement of the CCA-IMT does not add 
substantial information to the existing cardiovascular prognostic models risk [65]. Based 
on the results of this meta-analysis, the 2013 ACC / AHA International Prevention 
Guidelines downgraded IMT as a measurerement [66]. 
Measurements of CCA-IMT have a stronger prognostic value regarding stroke 
prognosis, while the endothelium of ICA (ICA-IMT) appears to predominate in the 
prognosis of cardiovascular events of atherosclerotic aetiology [53]. 
The echogenicity of Intima-Media (IM) 
 
Ultrasonographic IMT measurement is established in the clinical and research level, 
however the utility of measuring the echogenicity of the IM complex is under 
investigation [67]. Echogenicity measurements that have been performed on 
atherosclerotic plaques, have shown that echogenicity is associated with different 
histological characteristics of the plaque, such as elastin, calcium and the size of the lipid-
necrotic nucleus [68]. In study [69], IM's echogenicity was found to be associated with 
multiple cardiovascular risk factors, including inflammation and oxidative stress. In the 
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same study, the carotid IM morphology was found to be correlated with the echogenicity 
of the brachial artery’s endothelium. IMT of the brachial artery's is associated with 
different cardiovascular risk factors comparesd to its echogenicity, fact that indicates that 
the measurement of the echogenicity of IM involves different diagnostic information 
compared to the IMT measurement [70]. 
The measurement of atheromatous plaque echogenicity of the carotid artery may be a 
superior prognostic marker for stroke, however, the measurement of the echogenicity of 
IM can be an overall marker of vascular wall composition and of the instability of 
atherosclerotic plaques in other vascular compartments, having an impact on the total 
cardiovascular mortality [71]. A study published in 2009 included elderly men> 75 years 
old demonstrated that IM echogenicity can predict total cardiovascular mortality 
irrespective of IMT, the presence or absence of atherosclerotic plaque and its 
echogenicity. In addition, the predictive power of IM was also highlighted as independent 
of cardiovascular risk factors. This means that the measurement of the echogenicity of IM 
provides innovative predictive information on cardiovascular mortality at the age group 
above 75 years. In the same group of patients, the IM echogenicity was found lower in 
patients with a history of stroke compared to asymptomatic ones [72]. 
Morphological characteristics of atheromatous plaque 
 Irregular edge - Ulcerations 
Multiple ultrasound imaging parameters have been studied, indicative of the 
characteristics and composition of the atherosclerotic plaque. Some of these, such as the 
abnormality of the edge, echogenicity and heterogeneity (a combination of echolucency 
and echogenicity) have been associated with histopathological features of the vulnerable 
atherosclerotic plaque [73]. 
Regarding the irregularity of the edge, the ulcerations and the possibility to be detectable 
through B-mode ultrasound, the European carotid plaque study group revealed sensitivity 
and specificity 47% and 63%, respectively[74]. The presence of an abnormal edge in 
ultrasound can predict intraplaque hemorrhage with sensitivity and specificity 81% and 
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85%, respectively [75]. However, ultrasound analysis is limited (150-200 μm) to detect 
abnormalities at the edge of the atherosclerotic plaque; therefore, multiple studies 
compared the available imaging methods for the designation of ulcerations, and among 
them computed tomography angiography (CTA) proved to be the most effective one [76, 
77]. Saba et al demonstrated that CTA had a significantly higher sensitivity compared to 
ultrasound (93% versus 37.5%) [73]. Furthermore, MRI can detect the presence of ulcers 
with sensitivity similar to CTA [78]. 
In a recent study [78], MR using intravenous contrast was found to have significantly 
superior sensitivity compared to Time Of Flight (TOF) for the detection of ulceration 
(81.5% vs. 55%) [79]. 
 The texture of atheromatous plaque 
The classification of atherosclerotic plaques in homogeneous and heterogeneous, showed 
that the heterogeneous plaques contain more calcifications, without variations of the 
‘’soft’’ tissue concentration [80]. Homogeneous plaques have a uniform texture and 
smooth surface, while heterogeneous have a smooth or uneven surface [81]. 
The evaluation of heterogeneity of the atherosclerotic plaque improved the sensitivity of 
76% and the specificity of 85% regarding the detection of intraplaque hemorrhage 
compared to echolucency, while it predicts the thickness of the fibrous capsule of the 
atherosclerotic plaque (<80μm) as well as the location of the lipid nucleus with 77% and 
74% sensitivity and 22%, 17%, respectively [75]. 
 The fibrous capsule 
The fibrous capsule (FB) plays an important role in the possible instability of the 
atherosclerotic plaque, as its thickness and morphology comprise major determinants of 
potential rupture. Histologically, FB consists of smooth muscle cells in combination with 
an extracellular matrix that is associated with the presence of macrophages and T 
lymphocytes [82]. Inflammatory cells have also been found between the surface and the 
lipid nucleus [83]. 
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According to histological studies, vulnerable atherosclerotic plaques have a thin fibrous 
capsule and a large lipid-necrotic nucleus containing macrophages and collagen. Rupture 
of the FB and the "exposure" of thrombogenic subendothelial constituents of the plaque 
into the bloodstream leads to thromboembolic complications. The ideal imaging method 
for assessing the fibrous capsule is MRI, which classifies the fibrous capsule into normal, 
thin or eroded-ruptured. The thick fibrous capsule is depicted as a low signal region in the 
TOF sequences, which is not visible when the capsule is thin [84]. When the fibrous 
capsule is broken, the absence of the low signal band between the plaque and the lumen 
is foolowed by bleeding and/or a thrombus thrombus formation, represented as a region 
of high signal. 
Using MRI, Demarco et al [85] found a strong and statistically significant correlation 
between the ruptured fibrous capsule and ipsilateral stroke. The application of CT has 
been tested for the characterization of the fibrous capsule but without satisfactory results 
due to blurring effects, limiting the distinctive ability of the method [86]. 
Due to the low resolution of ultrasonography, its use is limited regarding the designation 
of the FB and therefore there are no relevant studies in the literature [79]. 
 Constitution and echogenicity of atheromatous plaque 
The echogenicity of the atherosclerotic plaque characterizes its morphology through the 
reflection of the ultrasound signal. Multiple studies have shown that vulnerable 
atherosclerotic plaques are composed of a large lipid core covered by a thin fibrous 
capsule. They also contain macrophages, a characteristic found in plaques of 
symptomatic patients and may also contain bleeding features. These plaques appear to be 
echolucent (with low echogenicity) in ultrasound (Figure 5). Plaques depicted as 
echogenic (with high echogenicity) have a higher content of collagen and fibrous tissue 
and are often calcified (Figure 6). 
Echolucent atherosclerotic plaques with prominent lipid or necrotic content are 
characterized by a greater risk of stroke or cardiovascular events compared to echogenic 
ones and are considered more prone to rupture [87, 88]. Follow-up studies of the history 
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of atherosclerotic carotid disease have shown that echolucent plaques are often associated 
with ipsilateral stroke [89,90]. The echogenicity associated risk of an atheromatous 
plaque has been found to be independent of the degree of stenosis, sex, age and other 
cardiovascular risk factors [91], while the combined study of echogenicity with IMT has 
been demonstrated to contribute more to the conventional prognostic models [ 92]. 
The assessment of echogenicity was initially proposed as a simple method for the 
prognosis of cardiovascular events during the performance of percutaneous treatment 
with stent placement. The Carotid Angioplasty and Risk of Stroke Study (ICAROS) 
showed that carotid atherosclerotic plaques were associated with an increased risk of 
stroke during percutaneous treatment [91]. A recent study [93] histologically confirmed 
the findings of the ICAROS study, as echolucent atherosclerotic plaques were found to 
release more embolic material during stent placement compared to echogenic ones. 
Finally, the increase in the atheromatic plaque echogenicity over a period of 6-9 months 
has been shown to have a predictive value for medium-term cardiovascular events in 
asymptomatic patients with a stenosis of> 30% [87]. 
 Qualitative evaluation of echogenicity 
The qualitative evaluation of the echogenicity of carotid atherosclerotic plaques is a 
visual categorization of their sonic reflections, largely dependent on the observer. 
Initially, in 1983 Reilly et al introduced the structural characterization of the carotid 
plaque into homogeneous (characterized by uniform, medium and high level reflexes) 
and heterogeneous (characterized by high, medium and low-level reflections) [81]. 
  In 1988, Gray-Weale described four different types of plaques, based on 
echogenicity: 
Type 1: Echolucent 
Type 2: Predominantly echolucent 
Type 3: Predominatly echogenic 
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Type 4: Echogenic atherosclerotic plaque [94]. 
In 1990, Widder et al applied an inverse classification with the most echolucent 
atherosclerotic plaques to be classified in category IV and the most echogenic in class I 
[95]. 
Finally, Geroulakis and his colleagues in 1993 introduced a modified version of the Gray-
Weale scale, adding a fifth category of atherosclerotic plaque or otherwise the 
"unclassified" atherosclerotic plaque, that due to its intense calcification, presents bands 
of acoustic shadow that blur the arterial lumen and the deepest arterial wall, rendering 
ultrasonographic imaging difficult [96]. 
 
Quantitative evaluation of echogenicity 
 GRAY SCALE MEDIAN (GSM) 
Elzatory in 1998 announced a method of computational image analysis, the system 
analysis of median scale of gray, the Gray Scale Median (GSM) [97]. This method allows 
a more objective and reproducible assessment of the atheromatic plaque echogenicity 
compared to visual categorization [98]. 
 The analysis is performed in digitized ultrasound images, which have been "normalized" 
to GSM of the blood (GSM 0-5) and GSM of the tunica adventitia (180-200). The 
echogenicity in the area of interest is expressed as 256 different tones of gray, where 0 is 
equivalent to black and 255 to white. Hence, atherosclerotic plaques with low GSM 
values are depicted echolucent, while plaques with high GSM values look echogenic. A 
strong correlation has been found between GSM and the concentration of fibrous-
calcified tissue within the atherosclerotic plaque while no correlation has been found 
between GSM and lipid core size, and various associations have been found with other 
plaque components [73]. 
Typically, atherosclerotic plaques with GSM values <25 have been associated with 
decreased elastin content, increased cellular load and increased DNA content [99, 100]. 
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In study [101], 87 patients with a grade of carotid stenosis > 50% were analyzed and was 
demonstrated that atherosclerotic plaques with a GSM value of <32 had an incidence 
55% of stroke, while atherosclerotic plaques with GSM> 32 had a stroke incidence of 
only 11%. Similar results were demonstrated in another study [102] where the incidence 
of stroke was 40% when GSM values were <50 and only 9% for GSM values > 50. These 
findings lead to the conclusion that echolucent plaques (plaques with low GSM values) 
that cause a narrowing of> 50%, are associated with an increased risk of stroke in 
asymptomatic patients. 
 In conclusion, the measurement of echogenicity by using GSM, could improve the 
criteria for selection of asymptomatic patients who are selected for operation [103]. 
 GSM ANALYSIS WITH COLOUR CODE 
The analysis using GSM is a mean value of the gray scale of the atherosclerotic plaque, 
without reflecting individual features of the plaque with prognostic significance, while at 
the same time it has low sensitivity (range 40-60%) for the detection of ‘’soft’’ ( GSM 
<35), mixed (GSM 35-65) and calcified (GSM> 65) atherosclerotic plaques [104]. 
Sztajzel [105] and his colleagues added color code to the GSM analysis with encouraging 
results. In particular, they studied each millimeter of the atherosclerotic plaque using 
three GSM bandwidths (GSM 50 = red, GSM 50-80 = yellow, GSM> 80 = green). The 
above analysis had a sensitivity of 84% and a specificity of 75% regarding the 
localization of the lipid nucleus. 
The GSM analysis combined with the color code, adapts GSM scales from various tissues 
(fat, muscle, blood, bone) in order to calculate the area occupied by each tissue in the 
atherosclerotic plaque. However, there are no analyzes regarding sensitivity and 
specificity of this method [106]. 
 INTEGRATED BACKSCATTER ANALYSIS (IBS) 
The GSM analysis of the atherosclerotic plaque involves the risk of systematic error in 
quantification of its echogenicity, as the image evaluation depends to a large extent on 
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the settings of the ultrasound machine, image compression techniques and ultrasound 
beam focus [107]. An experimental method designed to overcome the above mentioned 
problems and does not depend on the user of the ultrasound device, it is the integrated 
backscatter analysis (IBS), which is based on the processing of the primary 
electromagnetic signals (RF) resulting from the reflected energy of the ultrasound beam 
[108]. Quantitative methods based on the primary (RF) analysis override the processing 
that is subject to, the reflected signal by the signal processor of the ultrasound device. 
This reflected signal contains information about the structural components of the 
atherosclerotic plaque and tissues, through which it is transmitted, providing useful 
diagnostic information [109]. The echogenicity of the atherosclerotic plaque as it results 
from the IBS analysis, it has been found to predict the lipid content of the plaque, and the 
echolucent plaques, with low IBS values, are recognized as lipid-rich, vulnerable 
atherosclerotic plaques [110]. 
In addition, IBS analysis has been found to distinguish "soft", fibrous and calcified tissue 
in the atherosclerotic plaque. However, conflicting results have been published regarding 
the ability to separate individual "soft" characteristics from the healthy wall of the vessel. 
This may be due to the different methods of calculating the reflected energy [111]. 
 
Neovascularization – quantitative analysis with contrast-enhanced ultrasonography 
(CEUS) 
Intraplaque neovascularization is another indicator of vulnerable atherosclerotic plaque 
[77, 73]. Intraplaque neovascularization, originating from vessels of the vessels (vasa 
vasorum), is critical regarding the enlargement of the plaque. Vasa vasorum are 
functional, terminal arteries inside the wall of the aorta and large arteries that supply the 
vessel wall with nutrients and eliminating catabolism debris. They also promote 
inflammation in the atherosclerotic plaque. The new vessels are characterized by limited 
structural stability and their presence increases the risk of intraplaque bleeding and 
rupture of the atherosclerotic plaque [112]. These vessels are immature, thin-walled, and 
lipids, glucose and erythrocytes can escape from their walls, which in turn attract 
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macrophages, which can lead to the development of the atherosclerotic plaque [113]. 
Atherosclerotic plaques with high density of neo-vessels have increased risk of 
intraplaque bleeding and consequently rupture, which may lead to clinical events [114]. 
The possibility of detecting neovascularization in the atherosclerotic plaque by non-
invasive methods is of major clinical interest. CEUS is a promising tool for imaging 
neovascularization. This technique exploits both the high spatial resolution as well as the 
high-time analysis of vascular ultrasound and the properties of the microbubbles as a 
contrast medium [115]. 
Clinical [116] and experimental [117] studies have shown that the degree of 
atherosclerotic plaque enhancement is correlated with the density of neo-vessels in 
histological examination. Extensive neovascularization is associated with symptomatic 
and pathological "vulnerable" atherosclerotic plaques [118, 119, 120]. 
In a series of surgical endarterectomy preparations, a higher degree of neovascularization 
was found in symptomatic compared to asymptomatic plaques [119], while in ischemic 
stroke and/or TIA patients, the atherosclerotic plaque showed increased enhancement 
compared to asymptomatic patients [121]. A recent study also found increased carotid 
plaque enhancement in patients with acute coronary events compared to patients with 
stable cardiovascular disease, while at the same time enhancement of atherosclerotic 
plaque was an independent predictor of risk for future coronary events [122]. 
 
 Total plaque area (TPA) and total plaque volume (TPV) 
The measurement of TPA, such as IMT, is associated with future risk for manifestation of 
stroke and MI. Although these two measurements are closely related, they probably 
reflect different biological pathways and different stages of atherosclerosis. TPA 
measurement has been found to have a greater prognostic value than IMT for stroke. 
Repeated TPA measurements has been applied to monitor the effects of preventive and 
therapeutic measures on patients with known cardiovascular risk factors [123]. TPA 
monitoring can determine whether the effects of therapeutic intervention are satisfactory 
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or whether further investigation and intensive treatment of new cardiovascular risk 
factors, such as homocysteine and lipoprotein-α {Lp(a)}, is required in patients with a 
rapidly evolving atherosclerotic plaque who are already treated for the usual 
cardiovascular risk factors [124]. 
An interesting fact is that when patients see by their own eyes ultrasound images and 
TPA measurements, they are often motivated and are making changes in their lifestyle 
with beneficial effects (exercise, smoking cessation, strict diet, etc.). On the other hand, 
the gradual reduction of the plaque size encourages them to maintain these changes [125]. 
A major disadvantage of ultrasound is the two-dimensional mapping of the three-
dimensional carotid anatomy, which is responsible for the high degree of variability in 
diagnosis. For this purpose, the research interest has been focused on the development of 
three-dimensional ultrasound techniques that have the ability to reconstitute the 
conventional ultrasound imaging diagnostic information into three-dimensional images 
that can be studied on any computer later on. In addition, with the development of three-
dimensional ultrasound techniques, it is now possible to quantitate the total volume of 
TPV carotid atherosclerotic plaques and their surface morphology [126]. 
Changes in atherosclerotic plaque volume are more closely related to CAC than IMT. 
The three-dimensional measurements of the TPV of atherosclerotic plaque is the most 
sensitive method in terms of plaque changes from medical therapy compared to TPA 
[127]. 
Compared to IMT, TPV measurement significantly reduces the sample population and 
the follow-up duration required to study the effects of antiatherosclerotic drugs [128]. 
Elasticity index 
 Applanation tonometry 
With modern high-resolution ultrasound devices, it is now achievable to record the 
changes in carotid diameter during the heart cycle. Arterial distensibility reflects 
mechanical stresses and is a measurement of the elasticity and ability of the artery to 
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 18:08:58 EEST - 137.108.70.13
37 
  
stretch and contract during the cardiac cycle. Reduction of arterial distensibility leads to 
an increase in arterial stiffness and appears to be a common pathological mechanism for 
many factors that lead to the onset and progression of vascular changes associated with 
cardiovascular disease [129]. 
Arterial stiffness occurs as a consequence of increasing age, hypertension, DM, 
hypercholesterolemia and smoking [130]. 
Measuring pulse wave propagation velocity (PWV) with applanation tonometry is the 
most commonly used method of assessing arterial stiffness as it is simple on its 
application and also multiple studies have associated it with cardiovascular disease. 
Mathematically PWV is calculated by the Moens-Korteweg equation 
  
E is the coefficient of elasticity of the wall, h depicts he thickness of the arterial wall, r 
depicts the diameter of the vessel and p depicts the density of the blood. 
Measurement of PWV is a potentially very potent bio-indicator of atherosclerosis since 
arterial wall stiffness manifests well before the structural changes of the vessel occur 
[131]. 
Early diagnosis of this dysfunction can lead to more effective strategies in order to 
prevent cardiovascular disease [129]. 
 Flow-mediated dilation (FMD) 
The normal healthy endothelium regulates vascular tone by producing anticoagulants, 
antiplatelet and fibrinolytic agents. Vascular tone is maintained by the release of 
vasoconstrictors and vasodilators. Nitrogen monoxide (NO) is the major vasodilator and 
endothelial dysfunction occurs when the bioavailability of NO is reduced. FMD 
measurement is the most widespread non-invasive method for assessing endothelial 
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dysfunction. FMD reflects the ability of the brachial artery to distend after provocative 
reactive hyperaemia and is highly dependent on NO secretion. FMD measurement is 
based on the reactive hyperaemia caused by transient blockage of the brachial artery with 
the cuff of a sphygmomanometer. This reactive hyperemia is then studied by using Power 
Doppler Ultrasound. Traditional cardiovascular risk factors, such as smoking, obesity, 
glucose or lipid metabolism disorders, and hypertension have been associated with FMD 
disorder. In addition, disturbed FMD predicts the risk of future cardiovascular events and 
is a complementary indicator of total atherosclerotic burden [132]. 
 Virtual histology with intravascular ultrasound (VH-IVUS) 
VH-IVUS has been widely used in percutaneous coronary interventions for the accurate 
placement of stents. However, it is not a routine examination for carotids. VH-IVUS can 
recognize four subtypes of tissue including fibrin, fatty, necrotic, and calcified tissue. 
 The Carotid Artery Plaque Intravascular Ultrasound Evaluation (CAPITAL) [133] 
studied the types of atherosclerotic plaque in relation to the outcome of the patient after 
stent placement in the carotid artery and classified the different types of atherosclerotic 
plaque based on the localization and distribution of these tissues within the 
atherosclerotic plaque. In this study, the outcome of the operation was not correlated with 
the findings of VH-IVUS. VH-IVUS may characterize the morphology of the 
atherosclerotic plaque prior to stent placement, but its value in predicting microembolism 
as a complication of the intervention, is limited. However, it can be a useful method for 
identifying the morphology of the atherosclerotic plaque, contributing to the correct 
placement of the stent by improving the results of the interventional procedure. VH-
IVUS may also reveal areas of stenosis and calcification which are difficult to assess by 
angiography [134]. 
 New ultrasonographic indices with predictive value 
More sophisticated computational techniques of atherosclerotic texture analysis based on 
methodologies such as multiscale analysis and multiresolution analysis, can be effective 
methods in order to distinguish symptomatic from asymptomatic plaques. An interesting 
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finding in the case of wavelets analysis was that the dominant texture features were 
characterized by horizontal direction within the atherosclerotic plaque, highlighting the 
importance of mechanical effects (shear forces) on the texture [135]. 
In a recent study, the statistical features of the atherosclerotic plaque texture were found 
to be more sensitive to the effect of statins compared to TPV of the atherosclerotic plaque 
[136]. 
A recent approach to risk assessment for stroke is the combination of ultrasonographic 
markers associated with atherosclerotic plaque instability. A characteristic example is a 
combined study [137] of the echogenicity of the atherosclerotic plaque with the 
microembolic signals in the cerebral parenchyma recorded by transcranial Doppler 
ultrasound, demonstrated encouraging results regarding the improvement in the prognosis 
of stroke risk. 
Finally, quantification of the total plaque’s risk score by taking into consideration the 
degree of stenosis, edge irregularity, echogenicity and textural characteristics, has been 
proposed as the most potent predictor of cardiovascular events compared to FRS [138]. 
Necessary is the enhancement of the above findings by histological preparations of 
endarterectomy, as only a few studies have made a histological confirmation of the above 
risk assessment models [139]. 
 Multiscale transforms (wavelets, ridgelets, curvelets) who are used for image 
analysis 
The distribution of materials within the atherosclerotic plaque determines the spatial 
distribution of the gray in the ultrasound image. Such distributions can be characterized 
as: 
A) Low spatial frequencies namely slow changes in grayscale, where they may represent 
large areas occupied by a particular type of material. 
B) High spatial frequencies rapid, changes in grayscale, where they can represent 
different materials randomly distributed within the plate. 
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The texture can be defined as the distribution of gray levels in the image. The texture 
analysis in ultrasound images can describe the spatial distribution of the different 
gradientsvpf gray and hence the underlying distribution of materials. It is known that the 
effect of speckle due to multiple small randomly distributed reflections limits analysis 
and blurs the image, reducing the quality and reliability of ultrasound images. Although 
speckle is considered as noise (a high frequency component of the image), it is not 
standard random noise and may contain useful information. 
Texture analysis using multiple scales transformations such as: Gabor Filters (GB), 
Discrete Wavelet Transform (DWT), Stationary Wavelet Transform (SWT), wavelet 
packets (WPs) that appropriately decompose the image frequency content can reveal 
textural features of the atheromatous plate free from the effect of speckle noise. 
Whilst wavelet-based algorithms have been used in medical images for texture 
characterization, that they have disadvantages such as: limited texture information, and 
inaccurate information about the mid-range content of the image. In 2011, the prevailing 
texture characteristics were found to have a horizontal orientation, indicating that texture 
analysis can be influenced by biomechanical factors (shear forces exerted on the p;aque) 
[140] 
Recently multiscale geometric techniques such as transformations: ridgelets and curvelets 
were proposed for image processing. The above are an extension of wavelets and can 
capture geometric structural information of an image. Unlike wavelet methods where 
they can detect focal structures, the above can detect discontinuities along a line or curve 
of the image, often found in ultrasound carotid images. 
In particular, it was shown that curvelets (97.90%) exceed ridgelets (94.80%) as well as 
wavelets (89.90%) in correct tissue categorization of five living organs (heart, liver, 
spleen, kidneys and vertebral column). In the digital tomography of normal, benign and 
malignant cases the features extracted through the curvelet transforms lead to a better 
ranking (94.07%) compared to the characteristics extracted from the wavelets (90.05%). 
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Transformation of curvelets (CT) has been defined as the internal product of a bivariate. 
Function f (x) and curvelet ψα, b, θ (x): 
CT (α, β, θ) = ∫R2 ψα, b, θ (x) f (x) d (x) (6) 
where ψ, b, θ = a-3/4 ψ (DαRθ (x-b), Dα = (1/a 
it is a parabolic escalation and R 0 is an alternation of th radians. The parameter a is equal 
to 2-j, where j = 0, 1 ,. . . is the scale. The parameter θ = 2πl · 2-j / 2 is the angle of 
rotation where for l = 0, 1 ,. ., such that the location is defined by the sequence of the 
translation parameters. The function of the curvelets resembles a parabolic "wedge" 
(Figure 7).  
The first generation of discrete curvelet transforms (DCT) concerned an algorithm that 
was completed by entering zeros into the decomposition filters. The results of the 
decomposition (detailed sub-images) were parsed in squares and each was analyzed by 
the discrete ridgelet transforms (DRT). This is actually a local ridgelet transformation 
that suffers from the blocking effect. 
The second generation of DCT, ie the Fast Discrete Curvelet Transform (FDCT), has 
been shown to be direct and accurate [141]. It is based on a method of separation of 
frequencies, which comprises a) applying an FFT two-dimension to the image b) 
paraphrase image in a parallelogram for each scale and angle c) wrapping around the 
origin and d) applying the inverse two- FFT. 
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In the FDCT the number of angles for the second level was set to 20 (multiple of 4) and 
the combination of curvelets was used for coefficients in the first level. For each level 
only the first half of all coefficients was taken into account because the curvelets produce 
symmetric coefficients for the angles θ and θ + π. The total number of coefficients 
obtained was 22, resulting in 44 texture characteristics. 
The performance of the multiscale transformations was compared to that of the wavelets. 
The result of the comparison showed a clear superiority of the multiscale transformations 
with each form of wavelets (Gabor filters (GB), discrete wavelet transform (DWT), 
stationary wavelet transform (SWT) [140]. 
 
2. Methodology 
The study is based on bibliography search relating to the subject, via 
computerized database Pub Med-MEDLINE, using keywords. The review included 
single-center and multi-center investigations concerning carotid artery stenosis 
emphasizing on asymptomatic one and its correlation with cardiovascular comorbidities, 
especially with ischemic heart disease. The key-words that were used:  risk stratification, 
ischemic heart disease, asymptomatic carotid stenosis, intima-media thickness, carotid 
plaque 
The selection of the studies is based on the risk stratification for development of 
ischemic heart disease patients with asymptomatic carotid stenosis. This review is 
referred to studies that were published from 1981 until 2016. The aim of this systematic 
review of the bibliography is to stratify the risk for cardiovascular disorders, especially 
for IHD in patients with asymptomatic carotid stenosis, in order to assist in selecting 
potential candidates for cardiovascular intervention.  As the early recognition of patients 
at higher risk would maximize the potential benefits of revascularization or optimal 
medical therapy (OMT), as well as would ameliorate the prognosis. 
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Asymptomatic carotid stenosis as one of the major and most important consequences 
of generalized atheromatosis, often coexists with coronary artery disease. In addition, in a 
significant rate, an acute coronary event occurs in the background of asymptomatic 
carotid disease, therefore, the immediate diagnosis of carotid stenosis leads to the 
diagnosis of severe stenotic lesions of coronary arteries, preventing a potentially lethal 
coronary event. 
The correlation of these two conditions (asymptomatic carotid disease and coronary 
artery disease) varies according to the characteristics of the study population, the degree 
of carotid stenosis, the presence of symptoms or not, as well as to the selected study 
method and investigation. It is estimated that the coexistence of these two conditions 
range from 2 to 22% and comprise manifestations of the same disease, concretely of 
atherosclerosis with manifestations from different organs. 
Occasionally, several studies have been carried out in order to detect the degree of 
correlation between carotid stenosis and coronary artery disease, to identify risk factors, 
for stratifying patients to low, intermediate and high risk, and for the prediction of a 
future vascular event or coronary episode in particular. 
Among the oldest and most purposeful studies was that of Norris et al (1991) where 
the risk of vascular event was assessed in patients with asymptomatic carotid stenosis. A 
sample of 696 patients (369 women and 327 men) with a range of age between 45-90 
years was studied for a period of 6-95 months. Patients were screened by physical 
examination as well as by ultrasound study of the carotid system. Risk factors such as 
age, sex, obesity, smoking, family history, arterial hypertension, diabetes mellitus (DM), 
ischemic heart disease (IHD), peripheral artery disease (PAD) and total blood cholesterol 
levels were taken also into consideration and evaluation in the course of the study. These 
factors showed correlation with the degree of carotid stenosis, but not with the risk of 
cardiovascular events. This study demonstrated more men who were in older age with 
moderate-severe carotid stenosis. In addition, high levels of total cholesterol were 
recorded in patients with severe carotid stenosis, while men had a higher rate with severe 
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carotid stenosis compared to women. Finally, a large subgroup of patients with arterial 
hypertension and PAD belonged to the group with severe carotid stenosis [142]. 
The degree of carotid artery stenosis was classified by ultrasound scan findings 
categorizing it into mild to <50% stenosis, moderate with 50-75% stenosis, and severe 
stenosis> 75%. During the follow-up, 73 cardiac events (mainly myocardial infarction) 
occurred, from which a large group of 28 patients had mild carotid stenosis and out of a 
total of 59 deaths of cardiac etiology, the majority (42) were patients with mild-moderate 
carotid stenosis (Table 1.) 
TABLE A 
 
Table 1."Vascular Risks Stroke, Norris et al., 1991" 
The results of this study demonstrated that the annual risk of a cardiac event increases 
as the degree of stenosis increases, in particular 2.7% for stenosis <50% and 8.3% for 
severe stenosis> 75%. We should emphasize on the fact that these rates are significantly 
higher than those corresponding to transient ischemic attack (TIA) or stroke. 
The study of Nadareishvili et al (2002) was one of the most extensive researches on 
the long-term risk of stroke and MI in patients with asymptomatic carotid stenosis. In 
particular, it was evaluated the long-term risk for stroke and other vascular events such as 
MI and death of vascular etiology but not ischemic stroke and during the course of the 
follow-up. The screening of the patients included CDU of the carotid system and clinical 
evaluation annually. The study included 106 participants (44 men and 62 women) aged 
56-72 years who were screened for approximately 10 years, 50% of the patients for 10 
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years and the rest for 5 years. In the course of the follow-up were recorded cardiovascular 
events such as MI, ischemic stroke, TIA, death due to MI, PAD and heart failure (HF). It 
should be noticed the fact that 70% of the patients had arterial hypertension, 25% had 
DM and 11% were active smokers. 
Taking into consideration the results it is concluded that during the follow-up 10 
patients died from cardiac events and 10 had AMI. Overall, the 10-year and 15-year risk 
of MI was determined to 10.1% and 24% respectively, and the risk rate was significantly 
higher in patients with 50-99% stenosis of the internal carotid artery (ICA). The long-
term risk for MI in these patients was greater than the risk of cerebrovascular event or 
other vascular events. Age, gender, DM and carotid stenosis were important predictors of 
MI. In contrast, the long-term risk for cerebrovascular event was approximately 1% per 
year in asymptomatic carotid stenosis (Fig. 3) 
 
Figure 3." Survival without stroke and survival without myocardial infarction and death of non-cerebrovascular stroke 
origin in asymptomatic carotid artery stenosis" 
Thus, from this study it is concluded that in the future, the therapeutic approach of the 
asymptomatic carotid artery stenosis should primarily emphasize on the prevention of 
acute coronary events compared to the risk of ischemic stroke [143]. 
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SMART study (2007) tested the relation between asymptomatic carotid stenosis and 
the risk of vascular events in patients with known arterial disease. The study included 
2684 patients aged 18-79 years with clinical manifestations of arterial disease or DM type 
II, but without history of cerebral ischemia. It should be noticed that none of the patients 
underwent surgery for carotid disease. The degree of asymptomatic carotid stenosis was 
associated with a variety of vascular risk factors such as age, smoking, arterial 
hypertension and blood lipids levels. Blood glucose level, blood lipids levels, creatinine 
and homocysteine were recorded and the degree of carotid disease was determined based 
on the ultrasound findings of both carotids and the peak systolic velocity measurements. 
The results manifested that patients with asymptomatic carotid stenosis were older, 
smokers, with higher recordings of systolic arterial pressure, with higher levels of total 
cholesterol and LDL cholesterol and history of PAD. In the course of the follow-up, 239 
patients (9%) died, 49 (2%) experienced ischemic stroke, and 165 (6%) developed MI. 
The study showed direct correlation of the extent of carotid stenosis with the risk of 
developing MI. 172 patients with 30-49% asymptomatic carotid stenosis had an increased 
risk of AMI (1.2%), stenosis of 50-69% (74 patients) showed 1.5% risk, while stenosis of 
70-99% (96 patients) had 1,7% risk and total occlusion (51 patients) 1% risk (Table B). 
TABLE B 
 
Table 2. "Risk of Any Vascular Event in Relation to the Extent of Asymptomatic CAS" 
Totally, asymptomatic carotid stenosis equal or greater than 50% was recorded in 8% 
of patients and was associated with an increased risk of vascular event and MI occurred 
in 8% of patients after 5 years. In conclusion, asymptomatic carotid stenosis is an 
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independent risk factor for vascular events in patients with clinical manifestations of 
arterial disease or DM type II without having history of cerebral ischemia [144]. 
Correlation of coronary artery disease with that of atheromatosis of carotid arteries 
was confirmed by studies such as Kato et al., and Steinvil et al. In Steinvil’s et al., study 
participated 1405 patients aged 54-76 years old (77.2% men and 22.8% women) from 
January 2007 to May 2009, who underwent scanning with coronary angiography and 
CDU. The assessment of atherosclerosis of the internal carotid arteries was based on the 
diameter of the vessel by using B-MODE ultrasound, as well as by recording Peak 
Systolic Velocity (PSV) and End Diastolic Velocity (EDV) values by CDU. The 
classification of carotid disease was done as follows: a) Normal carotids were defined 
those with PSV <125 cm/s, without detectable atherosclerotic lesions, b) Mild carotid 
stenosis, with PSV <125 cm/s and luminal stenosis <50%, c) Moderate carotid stenosis, 
with PSV 125-230cm/s and luminal stenosis 50-70%, d) Severe carotid stenosis with 
PSV> 230cm/s and >70% stenosis. IHD was defined as the finding of atherosclerotic 
lesion that causes luminal stenosis above 70% in one of the epicardial coronary arteries 
(LAD, Lcx or RCA) while disease of the Left main coronary artery (LMD) was defined 
as stenosis of the lumen above 50%. 
From the results, as it shown in Table D, only 5.9% of patients with normal coronary 
arteries or without major stenosis, have carotid artery stenosis above 50%, while patients 
with 1 vessel disease (VD) have 6.6% rate, 13% is the rate for patients with 2VD, 17.8% 
in patients with 3VD and  31.3% in patients with LMD. Furthermore, it is important to 
note that in severe CAS (stenosis > 70%), coexist one or even more VD in a rate of 
approximately 24.5% (Table 3). 
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Table 3." Frequencies of CAS Severity by the Degree of CAD Severity" 
The statistical analysis of the results demonstrated that there is a strong correlation 
between the severity of the carotid stenosis and the extent of IHD. Notably, it is 
concluded that monitoring the progression of carotid disease can be really important 
regarding prognosis of future ischemic cardiac events or even death [145, 146]. 
In another study of Kato et al, participated 125 patients aged 53-73 years old with risk 
factors for vascular disease (smoking, DM, dyslipidemia, hypertension), who presented 
with ACS and underwent carotid ultrasound (morphological analysis of atherosclerotic 
plaque, measurement of IMT) and coronary angiography study within 24 hours of the 
ACS. The classification of the patients was based according to the number of vessel 
disease with critical lesions. The first class (50 patients) included those with single lesion, 
and the second class (75 patients) those with multiple lesions in the vessels. 
In patients with multiple coronary artery lesions, IMT values were higher than those 
in patients with single lesions, and likewise the percentage of atherosclerotic plaques with 
a large lipid core was higher, 28% in patients with multiple lesions, versus 12% in 
patients with single lesions. It is worthy to note that 72% of those patients with ACS were 
diabetic and had multiple lesions in the vessels (Table 4). 
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Table 4." Coronary Angiography Findings in ACS Patients With Single and Multiple Coronary Plaques" 
In this study we see that in patients with ACS the existence of multiple and complex 
atherosclerotic plaques in coronary arteries is related to positive remodeling of carotid 
arteries (i.e. mean IMT> 1.1mm diameter and diameter of tunica intima is above 8 mm), 
therefore, the vulnerability of atherosclerotic plaque may be a systemic phenomenon. 
In conclusion, we should remark that Kato’s et al study establishes the correlation of 
carotid and coronary artery disease (CAD) by investigating the correlation in morphology 
of atherosclerotic plaques of carotid arteries and coronary arteries following an acute 
coronary syndrome (ACS) [145]. 
Several studies were designed to detect the degree of correlation of IMT of the carotid 
atherosclerotic plaque and CAD, in particular regarding the prediction of ACS. Kuopio 
Ischemic Heart Disease study demonstrated that every increment of cIMT by 0.1mm was 
associated with 11% increased risk for MI. This one was the first study that highlighted 
the correlation of cIMT with future coronary events. 
In TROMSO study of Herder et al., where 2743 patients (1307 men and 1436 
women) participated, were established the risk factors that play an important role in the 
progression of IMT as well as in the total plaque area (TPA) of the atherosclerotic plaque. 
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In addition, we should remark that in this study was measured the IMT in regions without 
atheromatous plaque. Total plasma cholesterol levels, high-density lipoprotein (HDL) 
levels, smoking, blood pressure, DM, body mass index, and the presence of 
cardiovascular disease were included as parameters in the study. The subjects of this 
study underwent ultrasound scanning of the right carotid artery and got a follow-up for 13 
years.  
The results of this study revealed a higher percentage in the presence of plaques in 
men (41.6%) compared to women (32.6%), as well as a higher extent of atheromatosis, as 
the mean TPA and IMT was higher in men and in the course of the follow-up, the 
progression of IMT and TPA was also greater in men. In particular, another finding of the 
study was that the total cholesterol level, systolic blood pressure and smoking are 
stronger predictive factors for TPA progression than for IMT, whereas age and gender 
play a more important role in IMT progression. In conclusion, the carotid atherosclerotic 
plaque shows a stronger correlation with the existence of generalized atherosclerosis in 
comparison to the thickening of intima-media complex [149]. 
In several studies like ARIC, CHS and Coskun et al., highlighted the use of IMT as a 
non-invasive marker of IHD. In ARIC study was established the correlation of increment 
of cIMT with increased risk of IHD, in a study population of 15792 subjects where, 
carotid IMT (cIMT) was measured and a repeat measurement was recorded in a time 
interval of 4-7 years [148]. Likewise, in CHS study where involved 4476 subjects <65 
years of age for 6 years, confirmed the correlation of high cIMT values with increased 
risk of MI and cerebrovascular event [149]. 
Coskun et al., included in a study 100 patients with stable IHD and confirmed 
ischemia by stress test, in order to investigate the correlation of IMT with the extent of 
coronary vessel lesions by coronary angiography imaging. The patients were divided into 
2 groups, The first one comprised 39 patients with non-critical coronary artery stenosis, 
and the second group (with more risk factors) included 61 patients with> 50% coronary 
artery lesions. 
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Table 5." OMT & Carotid Plaque as Prognostic of Cardiovascular Events" 
Finally, the recordings showed that the IMT value in group 2 (mean IMT: 0.78 ± 
0.21) was statistically higher compared to group 1 (mean IMT: 1.48 ± 0.28). (TABLE 
ST) In conclusion, in this study, the increase in IMT is related to the presence and extent 
of IHD according to angiographic measurements. [150] 
Epidemiological studies have demonstrated that non-invasive atherosclerotic markers 
such as coronary artery calcium (CAC) score and IMT are major predictive markers of 
future cardiovascular events. There is a significant number of studies supporting the role 
of CAC score regarding the prognosis of MI and cardiac mortality. In combination with 
already existing risk stratification algorithms such as the Framingham Risk Score, 
European Systematic Risk Assessment and ProCAM studies, CAC score use is getting 
increasingly widespread (Table 6). 
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Table 6." Risk factors contributing to 10-year risk of CHD" 
According to the guidelines of the major societies of cardiology worldwide, there is a 
strong recommendation to modify risk factors especially in high-risk patients for an acute 
coronary event, while patients of intermediate risk may need further risk stratification 
based on CAC score. Several studies have been performed on investigating the value of 
CAC score in order to predict MI incidence, such as Greenland et al., Kondos et al. and 
Lamond et al., that approved the strong predictive value of CAC score concerning MI, in 
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combination with the classical cardiovascular risk factors. In particular, it was determined 
the risk of IHD based on the CAC score as follows: a) 1% for CAC score: 0, b) 1.9% for 
CAC score: 1-99, c) 4.3% for CAC score: 100-400, d) 7.2% for CAC score: 400-999, and 
e) 10.8% for CAC score: > 1000. Thus, we can remark the importance of CAC score in 
evaluating patients with asymptomatic carotid stenosis and high risk for coronary event 
[151, 152].  
MESA study in an average follow-up of 3.9 years (maximum 5.3 years) included 
6698 patients (3,161 men and 3,537 women) aged 45-84 years, investigated the 
predictive value of IMT measurement compared to Agatston score (CAC score) 
regarding the occurrence of cardiovascular events. Agatson score was determined by CT 
scan, as well as IMT was measured in common and ICA bilaterally. The end-point of the 
follow-up was defined by recording the first cardiovascular event. 
Overall were recorded 222 cardiac events (61 AMI, 81 episodes of Angina, 3 
succesful resuscitations from cardiac arrest and 13 deaths), 59 strokes (3 of them with 
concurrent cardiovascular event) and 7 deaths of other cardiovascular origin. For patients 
with moderate CAC score and high IMT, the annual cardiovascular event rate was 1-2%, 
while for patients with a high CAC score and moderate or high IMT, the rate was >2%. 
Results showed that CAC is a better prognostic marker for cardiovascular events than 
IMT values [153]. 
Also was confirmed the predictive value of CAC score and additionally, approved 
that the estimation of TPA of the atherosclerotic plaque is an even stronger prognostic 
marker compared to CAC score. One more important note from those studies is that IMT 
measurement was a better prognostic marker for stroke. 
IMT of carotid artery and Agatson score are associated with classical cardiovascular 
risk factors and play an important role in the progression of atherosclerotic disease of the 
peripheral but also of the coronary arteries.  A significant number of studies recommends 
Agatson score and IMT measurement in asymptomatic patients >50 years old for the 
detection of high-risk individuals for cardiovascular events as a guide for clinic decisions. 
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In ROTTERDAM study was studied the contribution of IMT in predicting IHD and 
in detecting high-risk individuals, when this is added to other classical risk factors such 
as plasma lipids levels, smoking, arterial hypertension and DM, compared to the 
predictive power of the IMT when it is used alone. The study included 385 subjects over 
55 years old with a follow-up period of 0.1 to 6.5 years. Parameters of the study: medical 
history, blood pressure recordings determination, lipid profile determination, ECG 
monitoring, as well as IMT measurements (the mean of 3 measurements in the right and 
left carotid arteries). During follow-up, 174 patients manifested MI, 165 stroke and 11 
presented both with MI and stroke. 
Despite the strong correlation between IMT values and future coronary events, the 
analysis of the results revealed that the independent measurement of IMT has the same 
prognostic value for the detection of high-risk patients for IHD with the other classical 
risk factors and its use, as a screening tool for identifying these patients adds nothing 
more [154]. 
In addition to the studies with regard to the risk of cardiovascular event in 
asymptomatic carotid stenosis, several studies had as a subject of investigation the risk 
stratification in patients with asymptomatic carotid stenosis who are treated either 
pharmaceutically or invasively (endarterectomy or stent placement). 
Wallaert et al. in 2013 attempted to provide a predictive model based on the 5-year 
survival rate of patients (taking into consideration patient’s benefit) with asymptomatic 
carotid disease who underwent endarterectomy, regarding the decision-taking for the 
appropriate time of the invasive treatment. For 8 years follow-up 4114 subjects with a 
mean age of 70, with asymptomatic carotid disease and with no prior history of any 
vascular event originating from the carotid disease were subjected to selective CEA. 89% 
of the patients had arterial hypertension, 80% were smokers and 33% had IHD. Patients 
were classified according to the risk of mortality as low, intermediate and high risk. 
Overall, 27% of the patients were classified as low-risk, 65% as intermediate-risk and 
only 5% were of high-risk. The results demonstrated 5-year survival rate of 82%, the 
perioperative mortality rate was extremely low at 0.4% in the first 30 days, and the stroke 
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rate was 0.6%. The 5-year survival rate for low-risk patients was 94%, and for the other 
two classes was 80% and 51%, respectively. Aggravating factors such as smoking, 
increased age, severe grade of renal failure, DM, HF, chronic obstructive pulmonary 
disease (COPD) and bilateral internal carotid artery stenosis were directly correlated with 
worse 5-year survival [155]. 
In conclusion and based on the latest guidelines, the candidate-patients for 
endarterectomy should have a life expectancy of at least 3 years with perioperative risk of 
vascular event/death below 3% in order to benefit the patient from the operation. In 
addition, high-risk patients do not show benefit from endarterectomy and maybe, the 
most appropriate treatment is medical therapy. Hence, this study highlighted the fact that 
there are high-risk patients with asymptomatic carotid disease who do not benefit from 
preventive CEA and concurrently provided a tool for selecting appropriate patients. 
In 2012 Prateek Gupta et al., investigated the probability of elicitation AMI, stroke or 
death within 30 days after CEA for asymptomatic carotid stenosis, in order to make 
easier the preoperative assessment of patients, as well as the selection of appropriate 
patients for CEA.  In this study, participated 17692 patients with a mean age of 72 years 
(57.9% men), who were operated electively for CEA. 
Patients were classified into three categories (low, moderate and high-risk) based on 
the later parameters: 1) Age, 2) Shortness of breath, 3) Angina pectoris within 1 month, 
4) History of PAD and 5) History of COPD. The majority of patients (86.2%) were in the 
low-risk category, while only 1.2% of them were at high-risk. The exclusion criteria of 
the patients were: a) Cerebrovascular event with or without neurological manifestation, b) 
History of TIA, stroke c) tumor of CNS, d) Mobility disorders (hemiplegia, paraplegia, 
quadriplegia), e) Esophagitis, ascites, cancer, open trauma, transfusion, f) Chemotherapy 
30 days ago, radiotherapy 90 days ago, g) Sepsis. 
Within 30 days of CEA, 167 patients (0.9%) were diagnosed with stroke, 108 patients 
(0.6%) were diagnosed with MI and 72 patients (0.4%) died. The overall risk for the 
aforementioned events was 1.8%. Remarkable fact from the results is that patients <60 
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years of age had a higher risk of stroke compared to those aged 60-79 years, and those 
aged> 80 years were at higher risk for stroke, MI and death after CEA. 
Finally, this is one more study focusing on the proper selection of patients with 
asymptomatic carotid stenosis to perform CEA, taking into consideration, the 
comorbidities of the patients [156]. 
In another study of Cohen et al. in 1993 [157], was demonstrated that a group of 
patients with asymptomatic carotid disease benefits most from the conservative treatment 
of the disease with medication. In this investigation, 444 male patients of a mean age of 
64 years were followed-up for 4 years, in order to study the risk factors for mortality in 
patients with asymptomatic carotid stenosis that were treated with either medication or 
CEA. Eight clinical risk factors were associated with increased mortality: IHD, history of 
angina pectoris, congestive heart failure (CHF), peripheral vascular disease, intermittent 
claudication, DM, arterial hypertension history and abnormal ECG on admission. Three 
risk factors were associated with increased mortality rates: intermittent claudication, DM 
and abnormal ECG. While, angiographic prognostic factors of increased mortality 
included intracranial vascular disease and bilateral carotid stenosis. 
The total mortality in both groups (conservative treatment, CEA) was 37%, 61% of 
deaths were due to IHD, while no difference was observed in mortality rates among 
patients who were treated with either medication or surgically. We should also observe 
that the patient group treated with antiplatelet agent had a lower percentage of MI 
incidence, but not lower overall cardiovascular mortality rate [157]. 
In another study by Reed et al. in 2003, risk stratification was based on the presence 
of parameters such as CHF, coronary artery bypass graft (CABG) over 6 months, COPD, 
renal impairment (serum creatinine levels > 2mg/dl) and age > 80 years. The study 
reveald that in the absence of these factors the annual mortality is 5.6%, while the 
existence of one, two and three factors is associated with an annual mortality of 10.2%, 
10.6% and 13.2%, respectively [158]. In addition, parameters such as IHD, COPD and 
DM were associated with an increase in the overall mortality rate, while statin treatment 
and female sex were protective agents. 
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Nowadays, a new field of research is the incidence of anemia in CVDs. In the area of 
HF studies have proved that the existence of anemia in these patients significantly affects 
life expectancy and its correction may lead to improvement in symptoms and exercise 
capacity. Similar investigations have been attempted regarding the effect of anemia on 
total and cardiovascular’s origin mortality in patients with asymptomatic carotid stenosis. 
In the study of Goliasch et al., participated 1065 patients for a mean follow-up of 6.2 
years was attempted to define hemoglobin (HB) as a predictor of long-term mortality in 
patients with asymptomatic carotid disease. The protocol of the study included ultrasound 
study of the carotid arteries, detailed medical history taking, and a measurement of blood 
hemoglobin levels. 
According to the results of the study, 275 patients (25.8%) died, out of them, 66.2% 
(182 patients) died from cardiovascular cause, 27.6% (76 patients) from cancer, 1.8% (5 
patients) from chronic renal impairment and 4.4% (12 patients) ) died from other causes. 
The analysis of HB values and their correlation with the cardiovascular events of the 
study population showed a significant increase in overall mortality by decreasing HB 
values. The 6-year overall survival of the patients was 61% for HB values <12.9gr/dl, 
79% for HB values 12.9-13.9gr/dl, 80% for HB values 14-15gr/dl and 81% for HB values 
above 15gr/dl. 
In conclusion, there is a strong correlation between HB levels and the long-term 
mortality of patients with carotid disease and in addition it was observed that patients 
with low HB levels were at increased risk for cardiovascular events and death [159]. 
As mentioned above, in the studies of Wallaert et al., and Gupta et al, the correct 
selection of those patients with asymptomatic carotid stenosis that will be subject of CEA 
and simultaneously will benefit from that, it is an issue that requires consideration of 
many factors. The necessity for a diagnostic algorithm that might improve making-
decision has led to the search of new factors that could predict possible complications. 
Since MI is the major cause of perioperative and postoperative mortality and is much 
higher than the risk of stroke, risk stratification for CEA patients was attempted, by using 
homocysteine serum levels as a predictive marker [155, 156]. 
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In the single-centered study of Duschek et al (2013), the homocysteine (a known 
cardiovascular risk factor) levels was evaluated as a prognostic tool in patients with 
asymptomatic carotid stenosis who underwent CEA. The study population was 214 
patients, 126 men, 88 women, 130 of them above 75 years old and 84 subjects below 75 
years old, who underwent CEA and were followed-up annually for 8.5 years. 
Homocysteine plasma levels were determined in patients over 14 days prior to CEA. 
 According to this study the rate of perioperative stroke and death was 0.93%, a total 
of 22 stroke and 57 cardiac events were recorded and out of the 114 deaths overall, 32 
were cardiac, 15 of vascular cause and 47 of other etiology. 
This study observed also that the use of homocysteine levels in addition to other 
cardiovascular risk factors significantly increases the rate of risk assessment in patients 
with asymptomatic carotid stenosis, in an attempt to specify more accurately those 
patients who will benefit from CEA. On the other hand, patients with asymptomatic 
carotid disease and elevated levels of homocysteine undergoing CEA are at increased risk 
of cardiac death and maybe conservative treatment in these patients is more appropriate 
[160]. 
As a final comment, from the aforementioned studies and the meta-analyzes 
performed, while in patients with asymptomatic carotid stenosis who already receive 
optimal medical therapy (OMT), the percentage of stroke was significantly reduced to 
1% per year, it is not observed proportional reduction in the percentage of total mortality. 
Overall, 5-year mortality in patients with asymptomatic carotid stenosis > 50% is 23.6% 
(2.9% annually), while the mortality rates of cardiac origin ranging between 42-82%. In 
particular, in patients with asymptomatic carotid stenosis who are already on OMT, 
mortality rate is estimated approximately 24.35%, while in patients who underwent CEA 
the mortality rate is 22.7%. CEA's contribution to asymptomatic carotid stenosis is to 
reduce the annual risk for stroke - as demonstrated in ACAS 1995 and ACST 2004 - and 
not so much in reducing total and cardiac mortality [161]. 
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Atherosclerosis is a systemic inflammatory disease of the vessels and despite the progress 
in medicine the last years, both in the field of pharmaceutical treatment as well as in 
interventional therapies, MI and stroke are the main causes of death due to the disease. 
The incidence of asymptomatic carotid stenosis increases with age by 0.5% in subjects 
<50 years to 5-10% in patients >65 years in the general population. In addition, the 
incidence of asymptomatic carotid stenosis >50% was higher in patients with 
concomitant PAD 
4 Conclusions 
Carotid artery disease as a part of the group of the clinical manifestations of 
atherosclerosis, has a strong correlation with the ischemic heart disease. The presence of 
atheromatous plaques on carotid arteries amplifies the risk of myocardial infarction about 
3-5% annually. Approximately 25% of patients with carotid stenosis >70% 
simultaneously have ischemic heart disease, and about 12-15% of them show 3 vessel 
disease, while totally patients with asymptomatic carotid stenosis independently of the 
grade of stenosis, in approximately 40% of them coexist carotid artery disease. 
The classical cardiovascular risk factors influence and determine partly the extent  of 
carotid disease, while its evaluation in combination with markers like carotid intima-
media thickness (cIMT), coronary artery calcium (CAC) score and the atheromatic 
plaque, are useful tools regarding prognosis of future cardiovascular comorbidities, 
especially for myocardial infarction. The vulnerability of the atheromatic plaque is a 
systematic phenomenon, its study through specific non-invasive techniques and 
algorithms can provide a reliable assessment concerning future acute coronary events. 
Furthermore, despite the initial assumptions, carotid artery disease looks to be a precursor 
of myocardial infarction on a statistically significant grater rate compared to ischemic 
stroke. It should be mentioned that the lately, while it is observed significant reduction of 
the annual risk for ischemic stroke, mortality due to coronary artery disease in patients 
with asymptomatic carotid stenosis is higher in comparison to the healthy population. 
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Concerning the selection of appropriate therapy for patients with asymptomatic 
carotid stenosis, the risk of provocation iatrogenically of an acute cardiovascular event 
intraoperatively or postoperatively constitutes a key-decision making criterion. Carotid 
endarteriectomy (CEA) as well as carotid artery stenting (CAS) present both high rates of 
ischemic cerebrovascular events and acute coronary syndrome as side effects, especially 
in high-risk patients with life expectancy less than 3 years, which ones eventually 
optimization of medical therapy would be more appropriate. It should be noted that the 
all-cause and cardiac mortality in patients with asymptomatic carotid artery stenosis is 
still high despite its decrement in the general population. The majority of patients with 
asymptomatic carotid stenosis are categorized as high risk for coronary comorbidities and 
the aim for those patients is the maximum benefit that by modifying the risk factors and 
adding to the therapy statin. Furthermore, from guidelines of AHA/ACC of 2013, statin 
therapy in patients without symptoms of coronary artery disease and LDL levels between 
70-189mg/dl, causes reduction of all-cause mortality approximately 17% and about 28% 
of acute coronary comorbidities (fatal or non-fatal) [162]. 
 Despite the remarkable progression that has been achieved during the last decades 
concerning the diagnostic approach of atheromatous disease in general, the ischemic 
heart disease still needs to become further investigated. The total evaluation of patients, 
taking into consideration the past medical history, physical examination findings, 
cardiovascular risk factors, cardiovascular imaging findings (invasive and non-invasive), 
provide to the medical practice important tools regarding diagnosis, management and 
treatment of all clinical manifestations of atheromatous disease and especially ischemic 
heart disease. Group of patients who are on higher risk e.g. those with diabetes mellitus 
(DM), for whom regular follow-up in order to exclude possible existence of latent 
myocardial ischemia to achieve a better prognosis. 
 Taking into consideration results from meta-analyses regarding mortality rates in 
patients with asymptomatic carotid stenosis - the latest one Giannopoulos et al., 2015 – 
above 50%, 5-year mortality is approximately 23%, while 10-year mortality is 52,5%. In 
addition, 63% of all deaths were cardiogenic. Taking into account all the previously 
mentioned it is concluded that patients with asymptomatic carotid stenosis should be 
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considered as a high risk group for cardiovascular comorbidities, as the evolvement of 
atherogenic activity is already in advanced level. Special attention should be dedicated 
for patients with many risk factors and comorbidities like, smoking, age, sex, DM, renal 
failure, chronic obstructive pulmonary disease (COPD), hypertension, dyslipidemia 
[161]. 
 In addition, we should emphasize that the above mentioned group of patients 
should be part of a regular follow-up program in order to control the progression of 
carotid pathology, as well as for the detection of premature signs of myocardial ischemia, 
aiming to avoid fatal cardiac events, in combination with the modification of risk factors 
and the appropriate medical therapy. The future of research possibly is based on the gene 
approach of each disease and on the fully personalized diagnosis and treatment. 
 Furthermore, it is necessary for the discovery and application of diagnostic non-
invasive methods with low cost and with minimal side effects for predicting future 
cardiovascular events, as well as the identification of high-risk patients and their proper 
management with an integrated  follow-up program based on personalized treatment, 
aiming the reduction of cardiovascular mortality. 
While angiography remains the "gold standard" for the decision regarding the 
therapeutic management of carotid disease, studies are trying to prove the adequacy of 
the CDU and the clinical characteristics of the patient for the choice of treatment. The 
reason for the above mentioned sentence is because better results have been recorded 
with immediate (within 14 days since the neurological event) surgical or endovascular 
treatment. Obviously, CDU fulfills these conditions as it provides a convenient, 
immediate and uncomplicated result. Improvement on the accuracy and applicability of 
the CDU while avoiding neurological complications during the implementation of 
classical angiography, guided many health centers in taking a therapeutic decision relied 
only on CDU findings. Combination of MRA and CDU may be the most harmless and 
low cost preoperative imaging approach [163].  
The European Carotid Plaque Study Group having as a project-leader Henrik Sillesen, 
publishes [164] the first major preoperative comparison study of CDU evaluation of the 
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atherosclerotic plaque and its histological findings after endarterectomy. From the results 
in 270 patients, they conclude and suggest the therapeutic approach of asymptomatic 
patients with echolucent atheromatous plaque as potentially symptomatic and recommend 
endarterectomy. 
Fifteen years later, in 2009, [165] the European Vascular Surgery Society 
recommends the pre-invasive assessment of the carotid atherosclerotic plaque as a 
prerequisite for assessing its impact on successful outcome of therapeutic techniques and 
especially in CAS. Reliably now this can be achieved by using CDU and its classification 
according to GSM based on the analysis of the results with the assistance of electronic 
computer. It is the most common and at the same time the most reliable method of 
assessing Atheromatous plaque, as it is characterized by its easy applicability and wide 
range of availability. Really important fact is the examiner's experience as well as the 
quality of the ultrasound device. The thin and ulcerative fibrous capsule, the intense 
inflammatory process, neovascularization and the presence of a large fatty necrotic and 
hemorrhagic nucleus, characterize an atheromatous plaque as "unstable" and potentially 
symptomatic, which is delineated as echolucent and definitely more dangerous for 
neurological complications, especially in symptomatic patients. 
PARISK study [166] is expected interestingly, in patients with recent neurological 
event and stenosis <70%, will evaluate with non-invasive methods the constitution of the 
atheromatous plaque and the recurrence rate of stroke, in order to select earlier than 
relapse, the invasive treatment approach. 
The role of the fibrous capsule (FB) thickness of the atheromatous plaque 
regarding its stability has already been established. Nowadays MRI is the most sensitive 
method for the measurement of FB. Important is the evaluation of the plaque before 
applying the above mentioned high cost methods and 3D-CDU's development is expected 
interestingly regarding the imaging of FB [167]. Thus the therapeutic selection 
henceforward will depend on the parameter of FB. 
CDU and CEUS are the most documented methods for the selection of patients 
undergoing CEA or CAS [168]. More studies are expected to document the findings of 
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ultrasonography and in reference to the candidacy of patients for CEA in patients with a 
low degree of carotid stenosis.  
Ultrasound in all its forms, as analyzed above based on the International 
Bibliography, is the most widespread, low-cost, applicable to the majority of patients in 
order to evaluate the extent of carotid disease, especially at the bifurcation. Accepting as 
a disadvantage, the subjectivity of the ultrasound technique, simultaneous efforts should 
be noted for development of common ways of its evaluation, that is a powerful decision-
making tool for the therapeutic choice in both symptomatic and asymptomatic 
atherosclerotic disorder of the carotid bifurcation [169, 170]. 
The disease is characterized as asymptomatic or symptomatic depending on the 
clinical picture and patient’s history and the treatment decision is formally based on the 
degree of stenosis of the internal carotid artery. Concerns about the constitution of the 
atheromatous plaque, where CDU plays major role for its assessment, as well as the 
interest of completing some of the most promising studies, is expected to be lead the 
international scientific community to review the guidelines. The patient remains 
objectively asymptomatic or symptomatic, but the atherosclerotic plaque can now be 
considered as "potentially symptomatic" and treatment can be adapted according to the 
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